r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

BP

Brian T. Powl

Insider · Chief Commercial Officer · KURA

Brian T. Powl files insider transactions with the SEC as a chief commercial officer of Kura Oncology (KURA). We hold 4 disclosed purchases and sales filed since 29 June 2022, 1 of them in the last 90 days.

  • Files forKURA
  • Disclosed buys and sells4 in all, 1 in the last 90 days
  • Last disclosure24 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 14 August 2023 — 21 August 2026Chief Commercial Officer · Kura Oncology (KURA)21 Form 4 lines · source: SEC Form 4
  • Filed 27 June 2022 — 5 July 2023Chief Commercial Officer · Fate Therapeutics (FATE)4 Form 4 lines · source: SEC Form 4

Everything they disclosed

25 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.